ask="19.65"
ask_size="300"
average_daily_volume="553345"
bid="17.50"
bid_size="1000"
book_value="5.75"
change="+2.00"
change_from_200_day_moving_average="1.66"
change_from_50_day_moving_average="3.66"
change_from_52_week_high="-8.29"
change_From_52_week_low="7.46"
change_in_percent="+11.30%"
close="19.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.39"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="23963000"
high="20.35"
high_52_weeks="27.99"
last_trade_date="2/9/2017"
last_trade_price="19.70"
last_trade_size="14199"
last_trade_time="4:00pm"
low="17.70"
low_52_weeks="12.24"
market_capitalization="735.13M"
moving_average_200_day="18.04"
moving_average_50_day="16.04"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.83"
open="17.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+9.22%"
percent_change_from_50_day_moving_average="+22.79%"
percent_change_from_52_week_high="-29.62%"
percent_change_from_52_week_low="+60.95%"
previous_close="17.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.08"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="6.87"
stock_exchange="NMS"
symbol="GBT"
volume="1120012"
weeks_range_52="12.24 - 27.99"
